DOCSLIB.ORG

MITF in the Mouse Central Nervous System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

MITF in the mouse central nervous system Mitf expression and target genes in the olfactory bulb Anna Þóra Pétursdóttir Thesis for the degree of Master of Science University of Iceland Faculty of Medicine Department of Biomedical Sciences School of Health Sciences MITF in the mouse central nervous system Mitf expression and target genes in the olfactory bulb Anna Þóra Pétursdóttir Thesis for the degree of Master of Science Supervisor: Eiríkur Steingrímsson Instructor: Pétur Henry Petersen Masters committee: Jón Hallsteinn Hallsson Faculty of Medicine Department of Biomedical Sciences School of Health Sciences University of Iceland December 2010 MITF í miðtaugakerfi músarinnar Tjáning Mitf og markgen í lyktarklumbu Anna Þóra Pétursdóttir Ritgerð til meistaragráðu Umsjónarkennari: Eiríkur Steingrímsson Leiðbeinandi: Pétur Henry Petersen Meistaranámsnefnd: Jón Hallsteinn Hallsson Læknadeild Námsbraut í Líf- og læknavísindum Heilbrigðisvísindasvið Háskóla Íslands Desember 2010 Ritgerð þessi er til meistaragráðu í líf- og læknavísindum og er óheimilt að afrita ritgerðina á nokkurn hátt nema með leyfi rétthafa. © Anna Þóra Pétursdóttir 2010 Prentun: Háskólaprent Reykjavík, Ísland 2010 Mitf in the mouse central nervous system 3 ÁGRIP Mitf (microphthalmia-associated transcription factor) genið er vel varðveitt og er tjáning þess nauðsynleg fyrir þroskun litfrumna og einnig er það mikilvægt fyrir myndun sortuæxla. Mitf stökkbreyttar mýs skortir litfrumur í húð, hári og augum; þær eru blindar, með pínulítil augu (microphthalmia) og heyrnarlausar. Samkvæmt Allen Brain Atlas gagnagrunninum er Mitf tjáð í lyktarklumbu músa, en lyktarklumban er sá hluti heilans sem tekur á móti lyktarskilaboðum frá nefinu. Ekkert er vitað um hlutverk MITF í miðtaugakerfinu. Fyrra markmið þessa verkefnis var að staðfesta Mitf tjáningu í lyktarklumbu músa. Það var gert með RT-PCR og magnbundnum PCR mælingum. Seinna markmiðið var að ákvarða hvaða gen MITF hefur áhrif á í lyktarklumbunni og komast þannig nær því að ákvarða hlutverk þess í lyktarskyni. Annars vegar voru þekkt MITF markgen úr öðrum frumugerðum skoðuð og hins vegar framkvæmd genatjáningargreining á örflögu. Ekki reyndust nein af þeim þekktu markgenum sem valin voru vera markgen fyrir MITF í lyktarklumbu músa, nema hugsanlega Cma1. Úr örflögugreiningunni kom genið Sgcg helst til greina sem MITF markgen. Niðurstöður úr luciferasa prófi á stýrilsvæði Sgcg í HEK 293T frumum benda til þess að MITF virkji ekki tjáningu frá stýrilsvæði mSgcg. Hlutverk MITF í lyktarskyni var athugað með einföldum lyktarprófum. Niðurstöður þeirra sýndu að Mitfmi-vga9 arfhreinu mýsnar hafa ekki misst lyktarskynið, en mýs með minna MITF magn (Mitfmi-vga9 arfblendnar og arfhreinar mýs) virðast þó mögulega hafa minna þefskyn heldur en villigerðarmýs. Anna Þóra Pétursdóttir 4 Mitf in the mouse central nervous system Anna Þóra Pétursdóttir Mitf in the mouse central nervous system 5 ABSTRACT The Mitf (microphthalmia-associated transcription factor) gene is very well conserved and its expression is crucial for the development of both types of pigment cells and it is important for the development of melanoma skin cancer. Loss of function mutations in this gene cause loss of pigmentation in skin, hair and eyes, microphthalmia, blindness, and deafness. According to the Allen Brain Atlas database, Mitf is expressed in the mouse olfactory bulb (OB), the part of the brain that recieves olfactory information from sensory neurons in the nose. Nothing is yet known about the function of MITF in the CNS. The first aim of this project was to confirm Mitf expression in the mouse OB. This was done using RT-PCR and real time PCR. The second aim was to determine which genes MITF affects in the OB and thereby getting a better understanding of its function in olfaction. This was assessed by using both candidate gene approach and a microarray gene expression analysis. None of the genes selected through the candidate gene approach however appear to be MITF target genes in the mouse OB, except possibly Cma1. From the microarray analysis data one gene, Sgcg, is the most promising MITF target gene candidate. Co-transfection assay results for Sgcg promoter in HEK 293T cells suggest that MITF does not activate expression from the mSgcg promoter. MITF function in olfaction was tested with simple olfactory tests. The results showed that Mitfmi-vga9 homozygous mice have not lost their ability to smell, although their olfactory capabilities are perhaps not as good as that of Mitfmi-vga9 heterozygous and wt mice. Anna Þóra Pétursdóttir 6 Mitf in the mouse central nervous system Anna Þóra Pétursdóttir Mitf in the mouse central nervous system 7 ACKNOWLEDGEMENTS All the work in this project was performed in Læknagarður and the project was partly funded by Rannís. First of all I want to offer my thanks to my supervisors on this project, Eiríkur Steingrímsson and Pétur Henry Petersen, for allowing me the opportunity to work on this project and for their instruction and support. I would also like to thank Eiríkur for providing the mice used in this project. I want to really thank all the people at Læknagarður who supported this project. These include: Kristín Bergsteinsdóttir for teaching me all about working with RNA and for providing me with cDNA from mouse hearts and skin, Finnbogi R. Þormóðsson for his support, wisdom and amusing anecdotes, Indíana Elín Ingólfsdóttir for her help with the PC12 cell line and her undying support, Helga Eyja Hrafnkelsdóttir for her endless support, Marteinn Þór Snæbjörnsson for all his help, advice, and interesting conversations, the people at the Stem Cell Research Unit (SCRU) for all their help and advice, Alexander Schepsky for helping me with the luciferase assay and providing some of the plasmids used, Guðrún Valdimarsdóttir for her help on analyzing the microarray data, Christian Praetorius for his help and for providing lists of known MITF target genes, Christine Grill for helping me with the luciferase assay data analyzis, Benedikta S. Hafliðadóttir for her help and advice, Lilja Guðrún Steinsdóttir for providing the rats used in the project, and all the other people at Læknagarður who supported me in any way. I would also like to thank the third member of my master’s committee, Jón Hallsteinn Hallsson at the Agricultural University of Iceland for reading this thesis and providing me with good advice, Fulvio Celsi at Sector of Neurobiology, International School for Advanced Studies (SISSA), Anna Þóra Pétursdóttir 8 Mitf in the mouse central nervous system Trieste, Italy, for providing the PC12 cells, and Satoru Noguchi (Department of Cell Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, Kodaira, Tokyo, Japan and Inheritance and Variation Group, PRESTO, Japan Science and Technology Corporation, Kawaguchi, Saitama, Japan) for providing plasmids for the luciferase assay. Last but not least I want to thank my family: my boyfriend Óskar Jónsson, my parents Sigurveig Knútsdóttir and Pétur Örn Björnsson, my sister Eva Margrét Pétursdóttir, and also my friends – for always listening and supporting me, for their patience and encouragement. Thank you all! Anna Þóra Pétursdóttir Mitf in the mouse central nervous system 9 TABLE OF CONTENTS ÁGRIP ....................................................................................................................... 3 ABSTRACT .............................................................................................................. 5 ACKNOWLEDGEMENTS .................................................................................... 7 TABLE OF CONTENTS ......................................................................................... 9 FIGURES AND TABLES ..................................................................................... 11 ABBREVIATIONS ................................................................................................ 13 I. INTRODUCTION ............................................................................................. 15 1.1 MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR (MITF) ............... 15 1.1.1 MITF ..................................................................................................... 15 1.1.2 The discovery of Mitf ............................................................................ 16 1.1.3 Mitf conservation .................................................................................. 17 1.1.4 Isoforms ................................................................................................ 18 1.1.5 MITF – a key regulator in melanocytes ................................................ 19 1.1.6 Mitf mutations and pathology ............................................................... 20 1.1.7 MITF function – target genes ............................................................... 22 1.1.8 Background on transgenic mice used in this study ............................... 23 1.2 THE OLFACTORY BULB ................................................................................. 27 1.2.1 Olfaction ............................................................................................... 27 1.2.2 Olfactory bulb function and structure .................................................. 27 1.3 AIM ............................................................................................................... 33 II. MATERIALS AND METHODS .................................................................... 34 2.1 ANIMALS ......................................................................................................
Recommended publications
  • Targeting Lineage-Specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small Molecule Inhibitor of P300/CBP

    Targeting Lineage-Specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small Molecule Inhibitor of P300/CBP

    Author Manuscript Published OnlineFirst on September 28, 2018; DOI: 10.1158/1535-7163.MCT-18-0511 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Targeting lineage-specific MITF pathway in human melanoma cell lines by A-485, the selective small molecule inhibitor of p300/CBP Rui Wang1,2, Yupeng He1, Valerie Robinson1, Ziping Yang1, Paul Hessler1, Loren M. Lasko1, Xin Lu1, Anahita Bhathena1, Albert Lai1, Tamar Uziel1, Lloyd T. Lam1,3 1Oncology Discovery, AbbVie, 1 N Waukegan Road, North Chicago, IL 60064-6101, USA. 2Former AbbVie employee Running title: p300/CBP inhibition targets MITF in melanoma cell lines Keywords: p300/CBP inhibitor, melanoma, MITF, A-485, senescence Word count: 3,040 (excluding the abstract, references and legends) References: 29 3Correspondence: Lloyd T. Lam, Oncology Discovery, AP10-214, Dept. R4CD 1 North Waukegan Road North Chicago, IL 60064-6098, USA. Phone: 847-937-5585 Fax: 847-935-4994 E-mail: [email protected] Financial information Y.H., V.R., Z.Y., P.H., L.M.L., X.L, A.B., A.L., T.U., L.T.L. are employees of AbbVie. R.W. was an employee of AbbVie at the time of the study. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the manuscript. R.W., Y.H., V.R., Z.Y., P.H., L.M.L., X.L, A.B., A.L., T.U., L.T.L. have nothing to disclose. Downloaded from mct.aacrjournals.org on September 27, 2021.
  • Comprehensive Sequence Analysis of Nine Usher Syndrome Genes in The

    Comprehensive Sequence Analysis of Nine Usher Syndrome Genes in The

    Genotype-phenotype correlations J Med Genet: first published as 10.1136/jmedgenet-2011-100468 on 1 December 2011. Downloaded from ORIGINAL ARTICLE Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study Polona Le Quesne Stabej,1 Zubin Saihan,2,3 Nell Rangesh,4 Heather B Steele-Stallard,1 John Ambrose,5 Alison Coffey,5 Jenny Emmerson,5 Elene Haralambous,1 Yasmin Hughes,1 Karen P Steel,5 Linda M Luxon,4,6 Andrew R Webster,2,3 Maria Bitner-Glindzicz1,6 < Additional materials are ABSTRACT characterised by congenital, moderate to severe published online only. To view Background Usher syndrome (USH) is an autosomal hearing loss, with normal vestibular function and these files please visit the recessive disorder comprising retinitis pigmentosa, onset of RP around or after puberty; and type III journal online (http://jmg.bmj. fi com/content/49/1.toc). hearing loss and, in some cases, vestibular dysfunction. (USH3), de ned by postlingual progressive hearing 1 It is clinically and genetically heterogeneous with three loss and variable vestibular response together with Clinical and Molecular e 1 2 Genetics, Institute of Child distinctive clinical types (I III) and nine Usher genes RP. In addition there remain patients whose Health, UCL, London, UK identified. This study is a comprehensive clinical and disease does not fit into any of these three 2Institute of Ophthalmology, genetic analysis of 172 Usher patients and evaluates the subtypes, because of atypical audiovestibular or UCL, London, UK fi ‘ 3 contribution of digenic inheritance. retinal ndings, who are said to have atypical Moorfields Eye Hospital, Methods The genes MYO7A, USH1C, CDH23, PCDH15, ’ London, UK Usher syndrome .
  • Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome

    Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome

    RESEARCH ARTICLE Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome Samia Abdi1,2,3, Amel Bahloul4, Asma Behlouli1,5, Jean-Pierre Hardelin4, Mohamed Makrelouf1, Kamel Boudjelida3,6, Malek Louha7, Ahmed Cheknene3,8, Rachid Belouni2,3, Yahia Rous3,8, Zahida Merad3,6, Djamel Selmane9, Mokhtar Hasbelaoui10, Crystel Bonnet11, Akila Zenati1, Christine Petit4,11,12* 1 Laboratoire de biochimie génétique, Service de biologie - CHU de Bab El Oued, Université d'Alger 1, 16 Alger, Algérie, 2 Laboratoire central de biologie, CHU Frantz Fanon, 09 Blida, Algérie, 3 Faculté de médecine, Université Saad Dahleb, 09 Blida, Algérie, 4 Unité de génétique et physiologie de l’audition, INSERM UMRS1120, Institut Pasteur, 75015, Paris, France, 5 Faculté des sciences biologiques, Université des sciences et de la technologie Houari Boumédiène, 16 Alger, Algérie, 6 Service d’ophtalmologie, CHU Frantz Fanon, 09 Blida, Algérie, 7 Service de biochimie et de biologie moléculaire, Hôpital Armand Trousseau, APHP, 75012, Paris, France, 8 Service d’ORL, CHU Frantz Fanon, 09 Blida, Algérie, 9 Service a11111 d’ORL, CHU Bab el Oued, 16 Alger, Algérie, 10 Service d’ORL, CHU Tizi Ouzou, 15 Tizi-Ouzou, Algérie, 11 INSERM UMRS 1120, Institut de la vision, Université Pierre et Marie Curie, 75005, Paris, France, 12 Collège de France, 75005, Paris, France * [email protected] OPEN ACCESS Abstract Citation: Abdi S, Bahloul A, Behlouli A, Hardelin J-P, Usher syndrome (USH) is an autosomal recessive disorder characterized by a dual sensory Makrelouf M, Boudjelida K, et al. (2016) Diversity of the Genes Implicated in Algerian Patients Affected by impairment affecting hearing and vision.
  • Identification of Differentially Expressed

    Identification of Differentially Expressed

    IDENTIFICATION OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS OF Tdrd7 NULL MUTANT MOUSE LENS by Shaili D. Patel A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the degree of Degree in Biological Sciences in Arts and Sciences with Distinction Spring 2014 Copyrights 2014 Shaili D. Patel All Rights Reserved IDENTIFICATION OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS OF Tdrd7 NULL MUTANT MOUSE LENS by Shaili D. Patel Approved: __________________________________________________________ Dr. Salil A. Lachke, PhD., Professor in charge of thesis on behalf of the Advisory Committee Approved: __________________________________________________________ Dr. Jeffery L. Caplan, PhD., Committee member from the Department of Delaware Biotechnology Institute Approved: __________________________________________________________ Dr. Rolf Joerger, PhD., Committee member from the Board of Senior Thesis Readers Approved: __________________________________________________________ Michelle Provost-Craig, Ph.D. Chair of the University Committee on Student and Faculty Honors ACKNOWLEDGMENTS First and foremost, I would like to thank Dr. Lachke, without whom this project would’ve been impossible. Thank you soooo much Dr. Lachke, I really hope I can be ten percent of what you are as a person. Additionally, I want to thank you for making such a big difference in my career, I am very thankful for that. Thank you mom and daddy for the roots and wings. Thank you Parth for being there every single day when I was finishing up my experiments and thesis, you were a great mental support and for being such a good friend. I would specially like to thank Carrie Barnum, who trained me in this lab. I will be taking all these lab skills to where I go in future, thanks a ton for that Carrie, and thank you for the little treats every once in a while; they were a great power booster J.
  • The Tudor Domain Protein Tapas, a Homolog of the Vertebrate Tdrd7, Functions in the Pirna Pathway to Regulate Retrotransposons in Germline of Drosophila Melanogaster

    The Tudor Domain Protein Tapas, a Homolog of the Vertebrate Tdrd7, Functions in the Pirna Pathway to Regulate Retrotransposons in Germline of Drosophila Melanogaster

    This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. The Tudor domain protein Tapas, a homolog of the vertebrate Tdrd7, functions in the piRNA pathway to regulate retrotransposons in germline of Drosophila melanogaster Patil, Veena S.; Anand, Amit; Chakrabarti, Alisha; Kai, Toshie 2014 Patil, V. S., Anand, A., Chakrabarti, A., & Kai, T. (2014). The Tudor domain protein Tapas, a homolog of the vertebrate Tdrd7, functions in the piRNA pathway to regulate retrotransposons in germline of Drosophila melanogaster. BMC Biology, 12, 61‑. https://hdl.handle.net/10356/84728 https://doi.org/10.1186/s12915‑014‑0061‑9 © 2014 Patil et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Downloaded on 25 Sep 2021 01:20:27 SGT Patil et al. BMC Biology 2014, 12:61 http://www.biomedcentral.com/1741-7007/12/61 RESEARCH ARTICLE Open Access The Tudor domain protein Tapas, a homolog of the vertebrate Tdrd7, functions in the piRNA pathway to regulate retrotransposons in germline of Drosophila melanogaster Veena S Patil1,4†, Amit Anand1†, Alisha Chakrabarti1,3 and Toshie Kai1,2* Abstract Background: Piwi-interacting RNAs (piRNAs) are a special class of small RNAs that provide defense against transposable elements in animal germline cells.
  • Impact of a Diet and Activity Health Promotion Intervention on Regional

    Impact of a Diet and Activity Health Promotion Intervention on Regional

    Hibler et al. Clinical Epigenetics (2019) 11:133 https://doi.org/10.1186/s13148-019-0707-0 RESEARCH Open Access Impact of a diet and activity health promotion intervention on regional patterns of DNA methylation Elizabeth Hibler1* , Lei Huang2, Jorge Andrade2,3 and Bonnie Spring1 Abstract Background: Studies demonstrate the impact of diet and physical activity on epigenetic biomarkers, specifically DNA methylation. However, no intervention studies have examined the combined impact of dietary and activity changes on the blood epigenome. The objective of this study was to examine the impact of the Make Better Choices 2 (MBC2) healthy diet and activity intervention on patterns of epigenome-wide DNA methylation. The MBC2 study was a 9-month randomized controlled trial among adults aged 18–65 with non-optimal levels of health behaviors. The study compared three 12-week interventions to (1) simultaneously increase exercise and fruit/ vegetable intake, while decreasing sedentary leisure screen time; (2) sequentially increase fruit/vegetable intake and decrease leisure screen time first, then increase exercise; (3) increase sleep and decrease stress (control). We collected blood samples at baseline, 3 and 9 months, and measured DNA methylation using the Illumina EPIC (850 k) BeadChip. We examined region-based differential methylation patterns using linear regression models with the false discovery rate of 0.05. We also conducted pathway analysis using gene ontology (GO), KEGG, and IPA canonical pathway databases. Results: We found no differences between the MBC2 population (n = 340) and the subsample with DNA methylation measured (n = 68) on baseline characteristics or the impact of the intervention on behavior change.
  • Gene Section Review

    Gene Section Review

    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Review TACC1 (transforming, acidic coiled-coil containing protein 1) Ivan Still, Melissa R Eslinger, Brenda Lauffart Department of Biological Sciences, Arkansas Tech University, 1701 N Boulder Ave Russellville, AR 72801, USA (IS), Department of Chemistry and Life Science Bartlett Hall, United States Military Academy, West Point, New York 10996, USA (MRE), Department of Physical Sciences Arkansas Tech University, 1701 N Boulder Ave Russellville, AR 72801, USA (BL) Published in Atlas Database: December 2008 Online updated version : http://AtlasGeneticsOncology.org/Genes/TACC1ID42456ch8p11.html DOI: 10.4267/2042/44620 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Note: - AK304507 and AK303596 sequences may be suspect Other names: Ga55; DKFZp686K18126; KIAA1103 (see UCSC Genome Bioinformatics Site HGNC (Hugo): TACC1 (http://genome.ucsc.edu) for more details. - Transcript/isoform nomenclature as per Line et al, Location: 8p11.23 2002 and Lauffart et al., 2006. TACC1F transcript Note: This gene has three proposed transcription start includes exon 1, 2 and 3 (correction to Fig 6 of Lauffart sites beginning at 38763938 bp, 38733914 bp, et al., 2006). 38705165 bp from pter. Pseudogene DNA/RNA Partially processed pseudogene: - 91% identity corresponding to base 596 to 2157 of Description AF049910. The gene is composed of 19 exons spanning 124.5 kb. Location: 10p11.21. Location base pair: starts at 37851943 and ends at Transcription 37873633 from pter (according to hg18-March_2006).
  • Supplementary Materials

    Supplementary Materials

    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
  • Homology Modeling and Global Computational Mutagenesis of Human Myosin Viia

    Homology Modeling and Global Computational Mutagenesis of Human Myosin Viia

    Journal of Analytical & Pharmaceutical Research Research Article Open Access Homology modeling and global computational mutagenesis of human myosin VIIa Abstract Volume 10 Issue 1 - 2021 Usher syndrome type 1B (USH1B) is a genetic disorder caused by mutations in the Annapurna Kuppa, Yuri V Sergeev unconventional Myosin VIIa (MYO7A) protein. USH1B is characterized by hearing loss Ophthalmic Genetics and Visual Function Branch, National Eye due to abnormalities in the inner ear and vision loss due to retinitis pigmentosa. Here, Institute, National Institutes of Health, Bethesda, United States we present the model of human MYO7A homodimer, built using homology modeling, and refined using 5 ns molecular dynamics in water. Global computational mutagenesis Correspondence: Yuri V. Sergeev, Ophthalmic Genetics was applied to evaluate the effect of missense mutations that are critical for maintaining and Visual Function Branch, National Eye Institute, National protein structure and stability of MYO7A in inherited eye disease. We found that 43.26% Institutes of Health, Bethesda, MD, United States, (77 out of 178 in HGMD) and 41.9% (221 out of 528 in ClinVar) of the disease-related Email missense mutations were associated with higher protein structure destabilizing effects. Overall, most mutations destabilizing the MYO7A protein were found to associate with Received: February 20, 2021 | Published: March 04, 2021 USH1 and USH1B. Particularly, motor domain and MyTH4 domains were found to be most susceptible to mutations causing the USH1B phenotype. Our work contributes to the understanding of inherited disease from the atomic level of protein structure and analysis of the impact of genetic mutations on protein stability and genotype-to-phenotype relationships in human disease.
  • Genetics of Azoospermia

    Genetics of Azoospermia

    International Journal of Molecular Sciences Review Genetics of Azoospermia Francesca Cioppi , Viktoria Rosta and Csilla Krausz * Department of Biochemical, Experimental and Clinical Sciences “Mario Serio”, University of Florence, 50139 Florence, Italy; francesca.cioppi@unifi.it (F.C.); viktoria.rosta@unifi.it (V.R.) * Correspondence: csilla.krausz@unifi.it Abstract: Azoospermia affects 1% of men, and it can be due to: (i) hypothalamic-pituitary dysfunction, (ii) primary quantitative spermatogenic disturbances, (iii) urogenital duct obstruction. Known genetic factors contribute to all these categories, and genetic testing is part of the routine diagnostic workup of azoospermic men. The diagnostic yield of genetic tests in azoospermia is different in the different etiological categories, with the highest in Congenital Bilateral Absence of Vas Deferens (90%) and the lowest in Non-Obstructive Azoospermia (NOA) due to primary testicular failure (~30%). Whole- Exome Sequencing allowed the discovery of an increasing number of monogenic defects of NOA with a current list of 38 candidate genes. These genes are of potential clinical relevance for future gene panel-based screening. We classified these genes according to the associated-testicular histology underlying the NOA phenotype. The validation and the discovery of novel NOA genes will radically improve patient management. Interestingly, approximately 37% of candidate genes are shared in human male and female gonadal failure, implying that genetic counselling should be extended also to female family members of NOA patients. Keywords: azoospermia; infertility; genetics; exome; NGS; NOA; Klinefelter syndrome; Y chromosome microdeletions; CBAVD; congenital hypogonadotropic hypogonadism Citation: Cioppi, F.; Rosta, V.; Krausz, C. Genetics of Azoospermia. 1. Introduction Int. J. Mol. Sci.
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024

    Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024

    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
  • LOTUS-Domain Proteins-Developmental Effectors

    LOTUS-Domain Proteins-Developmental Effectors

    Biol. Chem. 2021; 402(1): 7–23 Review Jana Kubíková, Rebecca Reinig, Harpreet Kaur Salgania and Mandy Jeske* LOTUS-domain proteins - developmental effectors from a molecular perspective https://doi.org/10.1515/hsz-2020-0270 domain is widely conserved in eukaryotes and bacteria, but Received August 2, 2020; accepted October 19, 2020; LOTUS domain-containing proteins have so far been published online November 4, 2020 studied experimentally only in animals; their role in bac- teria, fungi, and plants is not known. In animals, four Abstract: The LOTUS domain (also known as OST-HTH) is LOTUS domain proteins have been identified, namely a highly conserved protein domain found in a variety of Oskar, Tudor domain-containing protein 5 (TDRD5), bacteria and eukaryotes. In animals, the LOTUS domain is TDRD7, and Meiosis arrest female 1 (MARF1), recently re- present in the proteins Oskar, TDRD5/Tejas, TDRD7/TRAP/ named meiosis regulator and mRNA stability factor 1 Tapas, and MARF1/Limkain B1, all of which play essential (MARF1), all of which are essential developmental effectors roles in animal development, in particular during oogen- with a prominent function in gametogenesis (Figure 1; esis and/or spermatogenesis. This review summarizes the Table 1). The LOTUS domain comprises approximately 80– diverse biological as well as molecular functions of 100 amino acid residues and its fold resembles a winged LOTUS-domain proteins and discusses their roles as heli- helix-turn-helix (wHTH) domain (Anantharaman et al. case effectors, post-transcriptional regulators, and critical 2010; Callebaut and Mornon 2010; Jeske et al. 2015; Yang cofactors of piRNA-mediated transcript silencing.